The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative
Minxian Dai, Brandi Freeman, Fernando P. Bruno, Henry J. Shikani, Herbert B. Tanowitz, Louis M. Weiss, Sandra E. Reznik, Ralph A. Stephani, Mahalia S. Desruisseaux
Dive into the research topics of 'The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative'. Together they form a unique fingerprint.